TherapeuticsMD, Inc. - stock earnings
TXMD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -3.4 million USD | -53000 USD |
| 2023Q2 | -2.4 million USD | 437000 USD |
| 2023Q1 | -33.2 million USD | 1.2 million USD |
| 2022Q4 | 11051 USD | 103108 USD |
| 2022Q3 | -29.0 million USD | 20.9 million USD |
| 2022Q2 | 112.3 million USD | 28.6 million USD |
| 2022Q1 | -71.8 million USD | 19.3 million USD |
| 2021Q4 | -43.0 million USD | 18.7 million USD |
| 2021Q3 | -47.4 million USD | 25.4 million USD |
| 2021Q2 | -42.7 million USD | 23.0 million USD |
| 2021Q1 | -39.4 million USD | 19.9 million USD |
| 2020Q4 | -42.1 million USD | 22.6 million USD |
| 2020Q3 | -32.6 million USD | 19.3 million USD |
| 2020Q2 | -52.0 million USD | 10.7 million USD |
| 2020Q1 | -56.8 million USD | 12.3 million USD |
| 2019Q4 | -49.4 million USD | 15.9 million USD |
| 2019Q3 | -32.0 million USD | 23.7 million USD |
| 2019Q2 | -55.2 million USD | 6.1 million USD |
| 2019Q1 | -39.5 million USD | 3.9 million USD |
| 2018Q4 | -39.4 million USD | 5.1 million USD |
| 2018Q3 | -35.6 million USD | 3.5 million USD |
| 2018Q2 | -33.2 million USD | 3.8 million USD |
| 2018Q1 | -24.4 million USD | 3.8 million USD |
| 2017Q4 | -21.4 million USD | 4.1 million USD |
| 2017Q3 | -14.7 million USD | 4.4 million USD |
| 2017Q2 | -19.7 million USD | 4.3 million USD |
| 2017Q1 | -21.2 million USD | 4.0 million USD |
| 2016Q4 | -22.8 million USD | 4.5 million USD |
| 2016Q3 | -25.0 million USD | 5.5 million USD |
| 2016Q2 | -21.1 million USD | 4.4 million USD |
| 2016Q1 | -20.9 million USD | 4.9 million USD |
| 2015Q4 | -17.5 million USD | 5.6 million USD |
| 2015Q3 | -19.5 million USD | 5.2 million USD |
| 2015Q2 | -27.2 million USD | 4.8 million USD |
| 2015Q1 | -20.9 million USD | 4.5 million USD |
| 2014Q4 | -16.3 million USD | 4.3 million USD |
| 2014Q3 | -17.8 million USD | 4.2 million USD |
| 2014Q2 | -10.9 million USD | 3.8 million USD |
| 2014Q1 | -9.2 million USD | 2.8 million USD |
| 2013Q4 | -8.4 million USD | 2.9 million USD |
| 2013Q3 | -7.7 million USD | 2.3 million USD |
| 2013Q2 | -6.0 million USD | 2.1 million USD |
| 2013Q1 | -6.4 million USD | 1.5 million USD |
| 2012Q4 | -5.7 million USD | 1.2 million USD |
| 2012Q3 | -4.3 million USD | 1.0 million USD |
| 2012Q2 | -11.9 million USD | 819150 USD |
| 2012Q1 | -13.3 million USD | 721692 USD |
| 2011Q4 | -13.4 million USD | 2.1 million USD |
| 2011Q3 | -78530 USD | 2100 USD |
| 2011Q2 | -57072 USD | 508000 USD |
| 2011Q1 | -108847 USD | 20363 USD |
| 2010Q4 | -108847 USD | 20363 USD |
| 2010Q3 | 29951 USD | 22120 USD |
| 2010Q2 | -269087 USD | 5734 USD |
| 2010Q1 | -347392 USD | 15329 USD |
| 2009Q4 | -631311 USD | 10569 USD |
| 2009Q3 | -491260 USD | ? USD |
| 2009Q2 | -14169 USD | ? USD |
| 2009Q1 | -29033 USD | ? USD |
| 2008Q4 | -11902 USD | ? USD |
| 2008Q3 | -46505 USD | ? USD |
| 2008Q2 | -304465 USD | ? USD |
| 2008Q1 | -42212 USD | ? USD |
| 2007Q4 | -42212 USD | ? USD |
| 2007Q3 | 92936 USD | 242863 USD |
| 2007Q2 | 65946 USD | 225831 USD |
| 2007Q1 | 54372 USD | 221478 USD |
| 2006Q4 | 81739 USD | 187909 USD |
| 2006Q3 | 154153 USD | 368380 USD |
| 2006Q2 | 78317 USD | 209032 USD |
| 2006Q1 | 57806 USD | 232732 USD |
| 2005Q4 | 92616 USD | 281582 USD |
| 2005Q3 | 111763 USD | 254347 USD |
| 2005Q2 | 9355 USD | 204167 USD |
| 2005Q1 | 76153 USD | 194429 USD |
| 2004Q4 | 84329 USD | 175078 USD |
| 2004Q3 | 54782 USD | 176707 USD |
| 2004Q2 | 27672 USD | 139068 USD |
| 2004Q1 | -24667 USD | 131074 USD |
| 2003Q4 | 28487 USD | 122297 USD |
| 2003Q3 | 42226 USD | 90612 USD |
| 2003Q2 | 12345 USD | 121569 USD |
| 2003Q1 | 11051 USD | 103108 USD |
| 2002Q4 | 36055 USD | 97082 USD |
| 2002Q3 | 23416 USD | 74662 USD |
| 2002Q2 | 16623 USD | 65537 USD |
| 2002Q1 | 22818 USD | 49321 USD |
| 2001Q4 | -22416 USD | 45996 USD |
| 2001Q3 | 12618 USD | 71073 USD |
| 2001Q2 | 32039 USD | 93143 USD |
| 2001Q1 | 39294 USD | 122361 USD |
| 2000Q4 | 68953 USD | 130566 USD |
| 2000Q3 | 36751 USD | 91586 USD |
| 2000Q2 | 15034 USD | 77604 USD |
| 2000Q1 | 10930 USD | 69913 USD |
| 1999Q4 | -1386 USD | 68640 USD |
| 1999Q3 | 11839 USD | 58113 USD |
| 1999Q2 | 9410 USD | 46929 USD |
| 1999Q1 | -7433 USD | 40243 USD |
TXMD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 68.3 million USD | 69.4 million USD |
| 2022 | 112.0 million USD | 70.0 million USD |
| 2021 | -205.6 million USD | 87.0 million USD |
| 2020 | -212.7 million USD | 64.9 million USD |
| 2019 | -196.0 million USD | 49.6 million USD |
| 2018 | -132.6 million USD | 16.1 million USD |
| 2017 | -76.9 million USD | 16.8 million USD |
| 2016 | -89.9 million USD | 19.4 million USD |
| 2015 | -85.1 million USD | 20.1 million USD |
| 2014 | -54.2 million USD | 15.0 million USD |
| 2013 | -28.4 million USD | 8.8 million USD |
| 2012 | -35.1 million USD | 3.8 million USD |
| 2011 | -12.9 million USD | 2.1 million USD |
| 2010 | -695375 USD | 48217 USD |
| 2009 | -1.7 million USD | 10569 USD |
| 2008 | -395553 USD | ? USD |
| 2007 | 170542 USD | ? USD |
| 2006 | 373015 USD | 1.0 million USD |
| 2005 | 289887 USD | 934525 USD |
| 2004 | 142116 USD | 621927 USD |
| 2003 | 94109 USD | 437586 USD |
| 2002 | 98912 USD | 286602 USD |
| 2001 | 61535 USD | 332573 USD |
| 2000 | 131668 USD | 368022 USD |
| 1999 | 12430 USD | 214190 USD |
| 1998 | -15582 USD | 193971 USD |
| 1997 | -12738 USD | 193099 USD |
| 1996 | 73793 USD | 244051 USD |
| 1995 | 31511 USD | 195834 USD |
| 1994 | 34183 USD | 196780 USD |
| 1993 | 42579 USD | 201182 USD |
TXMD
Price: $1.88
52 week price:
Earnings Per Share: 4.85 USD
P/E Ratio: 0.46
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 688
Ebitda: -21.6 millionMarket Capitalization: 22.3 million